vs
Crown Castle（CCI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Crown Castle的季度营收约是Royalty Pharma plc的1.6倍（$1.0B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -45.9%，领先80.4%），Royalty Pharma plc同比增速更快（4.8% vs -4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -4.5%）
Crown Castle Inc.是总部位于美国得克萨斯州休斯敦的房地产投资信托企业，同时是美国共享通信基础设施服务商，在全球设有100个办事处，旗下拥有超4万座信号塔、约8.5万英里光纤线路，为小基站及光纤系统提供网络支撑。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CCI vs RPRX — 直观对比
营收规模更大
CCI
是对方的1.6倍
$622.0M
营收增速更快
RPRX
高出9.6%
-4.8%
净利率更高
RPRX
高出80.4%
-45.9%
两年增速更快
RPRX
近两年复合增速
-4.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $622.0M |
| 净利润 | $-464.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 46.0% | 62.4% |
| 净利率 | -45.9% | 34.4% |
| 营收同比 | -4.8% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $1.48 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCIRPRX
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.1B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M |
净利润CCIRPRX
| Q1 26 | $-464.0M | — | ||
| Q4 25 | $294.0M | $214.2M | ||
| Q3 25 | $323.0M | $288.2M | ||
| Q2 25 | $291.0M | $30.2M | ||
| Q1 25 | $-464.0M | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | $303.0M | $544.0M | ||
| Q2 24 | $251.0M | $102.0M |
毛利率CCIRPRX
| Q1 26 | — | — | ||
| Q4 25 | 97.4% | — | ||
| Q3 25 | 97.2% | — | ||
| Q2 25 | 97.5% | — | ||
| Q1 25 | 97.4% | — | ||
| Q4 24 | 97.7% | — | ||
| Q3 24 | 97.6% | — | ||
| Q2 24 | 97.7% | — |
营业利润率CCIRPRX
| Q1 26 | 46.0% | — | ||
| Q4 25 | 48.8% | 62.4% | ||
| Q3 25 | 49.0% | 70.1% | ||
| Q2 25 | 47.7% | 36.3% | ||
| Q1 25 | 49.1% | 94.0% | ||
| Q4 24 | 51.0% | 60.9% | ||
| Q3 24 | 47.5% | — | ||
| Q2 24 | 44.7% | 50.2% |
净利率CCIRPRX
| Q1 26 | -45.9% | — | ||
| Q4 25 | 27.5% | 34.4% | ||
| Q3 25 | 30.1% | 47.3% | ||
| Q2 25 | 27.5% | 5.2% | ||
| Q1 25 | -43.7% | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | 27.1% | 96.3% | ||
| Q2 24 | 22.7% | 19.0% |
每股收益（稀释后）CCIRPRX
| Q1 26 | $1.48 | — | ||
| Q4 25 | $0.67 | $0.49 | ||
| Q3 25 | $0.74 | $0.67 | ||
| Q2 25 | $0.67 | $0.07 | ||
| Q1 25 | $-1.07 | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | $0.70 | $1.21 | ||
| Q2 24 | $0.58 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $55.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $31.4B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CCIRPRX
| Q1 26 | $55.0M | — | ||
| Q4 25 | $99.0M | $618.7M | ||
| Q3 25 | $57.0M | $938.9M | ||
| Q2 25 | $94.0M | $631.9M | ||
| Q1 25 | $60.0M | $1.1B | ||
| Q4 24 | $100.0M | $929.0M | ||
| Q3 24 | $194.0M | $950.1M | ||
| Q2 24 | $155.0M | $1.8B |
总债务CCIRPRX
| Q1 26 | — | — | ||
| Q4 25 | $21.6B | $9.0B | ||
| Q3 25 | $21.6B | $8.9B | ||
| Q2 25 | $22.0B | $8.0B | ||
| Q1 25 | $22.9B | $7.6B | ||
| Q4 24 | $23.5B | $7.6B | ||
| Q3 24 | $23.5B | $7.6B | ||
| Q2 24 | $22.9B | $7.6B |
股东权益CCIRPRX
| Q1 26 | — | — | ||
| Q4 25 | $-1.6B | $9.7B | ||
| Q3 25 | $-1.5B | $9.6B | ||
| Q2 25 | $-1.4B | $9.5B | ||
| Q1 25 | $-1.3B | $9.8B | ||
| Q4 24 | $-133.0M | $10.3B | ||
| Q3 24 | $5.3B | $10.3B | ||
| Q2 24 | $5.7B | $9.8B |
总资产CCIRPRX
| Q1 26 | $31.4B | — | ||
| Q4 25 | $31.5B | $19.6B | ||
| Q3 25 | $31.5B | $19.3B | ||
| Q2 25 | $31.6B | $18.3B | ||
| Q1 25 | $31.8B | $17.6B | ||
| Q4 24 | $32.7B | $18.2B | ||
| Q3 24 | $38.0B | $18.0B | ||
| Q2 24 | $38.2B | $17.7B |
负债/权益比CCIRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 4.43× | 0.74× | ||
| Q2 24 | 4.04× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-43.0M | — |
| 自由现金流率自由现金流/营收 | -4.3% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $4.3B | — |
8季度趋势，按日历期对齐
经营现金流CCIRPRX
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $827.1M | ||
| Q3 25 | $714.0M | $702.6M | ||
| Q2 25 | $832.0M | $364.0M | ||
| Q1 25 | $641.0M | $596.1M | ||
| Q4 24 | $2.9B | $742.5M | ||
| Q3 24 | $699.0M | $703.6M | ||
| Q2 24 | $768.0M | $658.2M |
自由现金流CCIRPRX
| Q1 26 | $-43.0M | — | ||
| Q4 25 | $2.9B | — | ||
| Q3 25 | $671.0M | — | ||
| Q2 25 | $792.0M | — | ||
| Q1 25 | $601.0M | — | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $661.0M | — | ||
| Q2 24 | $729.0M | — |
自由现金流率CCIRPRX
| Q1 26 | -4.3% | — | ||
| Q4 25 | 268.4% | — | ||
| Q3 25 | 62.6% | — | ||
| Q2 25 | 74.7% | — | ||
| Q1 25 | 56.6% | — | ||
| Q4 24 | 247.3% | — | ||
| Q3 24 | 59.0% | — | ||
| Q2 24 | 65.9% | — |
资本支出强度CCIRPRX
| Q1 26 | 1.0% | — | ||
| Q4 25 | 17.0% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 15.7% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.5% | — |
现金转化率CCIRPRX
| Q1 26 | — | — | ||
| Q4 25 | 10.40× | 3.86× | ||
| Q3 25 | 2.21× | 2.44× | ||
| Q2 25 | 2.86× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 2.31× | 1.29× | ||
| Q2 24 | 3.06× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCI
| Site rental | $961.0M | 95% |
| Services and other | $49.0M | 5% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
